Convexity Labs

CCIX

Convexity Analyst · CCIX
Speculativelow confidenceTactical · no named thesis
Generated Jun 21, 2026

ANALYST NOTE: CCIX (Churchill Capital Corp IX) Date: 2026-06-12 Status: Context-Only / Tactical Setup

1. Structural Readiness

  • State: FORMING.
  • Conservative Entry: Not yet actionable. Requires a confirmed new merger agreement and a close above the consolidation range (typically >$10.50-$11.00 depending on immediate volatility).
  • Aggressive/Pre-Breakout Entry: $10.81 (Current Price). This represents a "forming" coil entry where the investor is betting on the successful execution of a new deal before the August 6, 2026 deadline.
  • Breakout Level: >$11.50 (Requires confirmation of a new deal and market acceptance).
  • Current Price: $10.81.
  • Extension: Minimal. The price is trading near the trust value, indicating the market is pricing in a binary outcome (deal or liquidation) rather than a growth premium.

2. Thesis Layer

  • Thesis Status: TACTICAL / SETUP-LED.
  • Analysis: There is no named secular thesis attached to CCIX as of this date. The investment case is not driven by a macro theme (e.g., "AI Infrastructure Boom" or "Green Energy Transition") but is purely a structural play on the SPAC merger process. The conviction must be derived entirely from the quality of the setup (the likelihood of a new deal closing before August 6, 2026) and the fundamentals of the target company once identified. Do not invent a thesis; judge this strictly on the probability of a successful business combination versus liquidation.

3. Business & Fundamentals

  • Current Business Model: CCIX is a Special Purpose Acquisition Company (SPAC). As of June 12, 2026, it is a shell entity with no operating revenue, holding cash in trust pending a business combination.
  • Industry: Financial Services / SPACs.
  • Supporting Evidence (PIT-Safe):
  • Target History: The company previously entered into a Merger Agreement with PlusAI (a Delaware corporation, likely a subsidiary or rebrand of "Plus Automation, Inc." as per [E8]) on June 5, 2025 ([E3], [E5]).
  • Valuation Context: The previous agreement valued PlusAI at a pre-money equity value of $1.2 billion ([E6]).
  • Deal Structure: The previous deal included an Earnout Period of five years, with up to 15,000,000 additional shares issuable to PlusAI holders ([E7]).
  • Termination: The PlusAI Merger Agreement was terminated by mutual consent on April 20, 2026, due to "market conditions" ([E2]).
  • Deadline Status: The company must complete an initial business combination by August 6, 2026, provided a definitive agreement was executed by May 6, 2026 ([E1], [E4]). Since the PlusAI deal was terminated in April, the company is currently in a race to find a new target or negotiate a new agreement before the August 6 deadline to avoid liquidation.
  • Sector Classification: Technology (as per the original target profile and current sector assignment).

4. Archetype & Conviction

  • Archetype: Quality Compounder (Potential) / Deep Value Recovery (Structural).
  • *Fit:* The name is currently classified as a "Quality Compounder" archetype based on the layer_a data, but this is a *potential* classification contingent on the successful merger. Currently, it functions as a Deep Value Recovery play on the trust value ($10.00) with an optionality premium for a successful deal.
  • Valuation Context: The current price of $10.81 implies a small premium over the trust value, suggesting the market is pricing in a non-zero probability of a successful new deal. The previous $1.2B valuation of PlusAI provides a reference point for the *type* of asset the SPAC seeks, but no current valuation exists for a new target.
  • Conviction Stack:
  • Thesis Strength: Low (No named macro thesis; purely tactical).
  • Evidence Quality: Moderate. The evidence confirms the *process* (deadlines, previous deal terms) but lacks the *new* target data required for a full fundamental assessment.
  • Setup Readiness: Partial. The coil is forming, but the breakout is pending a new agreement.
  • Rerating Potential: High *if* a deal is announced; Zero if liquidated.
  • ATR Context:
  • Current ATR: 0.6% (Sub-threshold). This indicates low volatility, consistent with a SPAC trading near trust value while awaiting news.
  • ATR at Breakout: Not applicable yet.
  • Interpretation: The low ATR suggests the market is in a "wait-and-see" mode. A breakout will likely require a significant volatility expansion (a "volatility spike") upon the announcement of a new target.

5. Invalidations, Strengths, and Gaps

  • What Would Invalidate:
  • A close below $10.00 (Trust Value). This would signal the market expects liquidation.
  • Failure to announce a new definitive merger agreement by August 6, 2026.
  • Management announcement of an extension vote failure or liquidation intent.
  • What Would Strengthen:
  • Announcement of a new definitive merger agreement with a named target.
  • Extension of the deadline via shareholder vote (if permitted by charter).
  • Significant inflow of PIPE (Private Investment in Public Equity) capital.
  • Gaps in Evidence:
  • Missing Target Identity: There is no evidence of a *new* target company as of June 12, 2026. The evidence base only covers the terminated PlusAI deal.
  • Missing Financials: No financial data for a new target exists.
  • Missing Management Guidance: No specific statements from management regarding the *current* search process or timeline for a new deal (other than the hard deadline).

PRIVATE ANALYST CALL

Judgment: Speculative Confidence: low Key risks: 1. Failure to secure a new merger agreement by August 6, 2026 leading to liquidation. 2. Market conditions (cited as reason for previous termination) may prevent a new deal. 3. No named target or financials available for due diligence. 4. Low ATR (0.6%) indicates lack of momentum; breakout may be delayed or fail. Sizing hint: Position size should be minimal (e.g., <1% of portfolio) due to binary risk and lack of fundamental data. Expected path: Management will likely announce a new target or extension request in the coming weeks; price will remain range-bound near $10.00-$11.00 until news. Expected horizon: 30 to 90 days (until August 6, 2026 deadline). Failure mode to watch: Price closes below $10.00 or management announces liquidation.

Loading chart...
Exhibit 1: CCIX daily candlestick — no active setup overlay.

Source-backed evidence anchors and catalysts land once Convexity finishes coverage for CCIX.

Core assumptions for this name haven't been articulated yet — they land alongside the rerating thesis.

Value picture unavailable — no financial spine on file for CCIX.

Layer B fundamentals snapshot not yet available. Highlights land once Convexity finishes the classification.

Coverage: